These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29024544)

  • 1. Squamous cell carcinoma in serous effusions: Avoiding pitfalls in this rare encounter.
    LePhong C; Hubbard EW; Van Meter S; Nodit L
    Diagn Cytopathol; 2017 Dec; 45(12):1095-1099. PubMed ID: 29024544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.
    Pu RT; Pang Y; Michael CW
    Diagn Cytopathol; 2008 Jan; 36(1):20-5. PubMed ID: 18064689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility and pattern of positivity of p40 in the diagnosis of squamous cell carcinoma of the lung by cytology: the first study on fine needle aspiration smears.
    Jain D; Mathur SR; Guleria R; Iyer VK
    Cytopathology; 2014 Oct; 25(5):330-5. PubMed ID: 24128123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ; Shin HC; Shin KC; Ro JY
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomorphological features of metastatic squamous cell carcinoma in serous effusions.
    Huang CC; Michael CW
    Cytopathology; 2014 Apr; 25(2):112-9. PubMed ID: 23594308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greater specificity of p40 compared with p63 in distinguishing squamous cell carcinoma from adenocarcinoma in effusion cellblocks.
    Kim NI; Lee JS
    Cytojournal; 2020; 17():13. PubMed ID: 32636920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistochemical analysis of a newly developed, mouse monoclonal p40 (BC28) antibody in lung, bladder, skin, breast, prostate, and head and neck cancers.
    Tacha D; Bremer R; Haas T; Qi W
    Arch Pathol Lab Med; 2014 Oct; 138(10):1358-64. PubMed ID: 24528495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.
    Tsuta K; Tanabe Y; Yoshida A; Takahashi F; Maeshima AM; Asamura H; Tsuda H
    J Thorac Oncol; 2011 Jul; 6(7):1190-9. PubMed ID: 21623236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytology of basaloid squamous cell carcinoma and small cell carcinoma of lung: a comparative study].
    He SR; Bai YP; Gong H; Di J; Chen L; Dai WD; Hu ST; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):237-42. PubMed ID: 27033386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of cell block to detect malignancy in fluid cytology: Adjunct or necessity?
    Dey S; Nag D; Nandi A; Bandyopadhyay R
    J Cancer Res Ther; 2017; 13(3):425-429. PubMed ID: 28862203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can p40 (Polyclonal) Replace p63 (Clone 4A4) in the Cytologic Diagnosis of Pulmonary Non-Small Cell Carcinoma?
    Alexander M; Chiaffarano J; Zhou F; Cangiarella J; Yee-Chang M; Simsir A
    Am J Clin Pathol; 2017 Jun; 147(6):580-588. PubMed ID: 28498881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
    Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of p53 and ki67 immunostaining for distinguishing benign from malignant serous effusions.
    Hafez NH; Tahoun NS
    J Egypt Natl Canc Inst; 2011 Dec; 23(4):155-62. PubMed ID: 22776843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63.
    Nobre AR; Albergaria A; Schmitt F
    Acta Cytol; 2013; 57(1):1-8. PubMed ID: 23221041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of SATB2 and MOC-31 Immunostains to Distinguish Between Poorly Differentiated Rectal Adenocarcinoma and Anal Squamous Cell Carcinoma.
    Fang JM; Assarzadegan N; Cheng J; Lamps L
    Appl Immunohistochem Mol Morphol; 2024 Sep; 32(8):357-361. PubMed ID: 39146227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of immunohistochemistry in distinguishing squamous cell carcinoma from mesothelioma and adenocarcinoma in pleural effusion.
    Li Q; Bavikatty N; Michael CW
    Semin Diagn Pathol; 2006 Feb; 23(1):15-9. PubMed ID: 17044191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis.
    Vogt AP; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2014 May; 42(5):453-8. PubMed ID: 24166777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of desmosomal plaque-related markers to distinguish squamous cell carcinoma and adenocarcinoma of the lung.
    Galindo I; Gómez-Morales M; Díaz-Cano I; Andrades Á; Caba-Molina M; Miranda-León MT; Medina PP; Martín-Padron J; Fárez-Vidal ME
    Ups J Med Sci; 2020 Feb; 125(1):19-29. PubMed ID: 31809668
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.
    Terry J; Leung S; Laskin J; Leslie KO; Gown AM; Ionescu DN
    Am J Surg Pathol; 2010 Dec; 34(12):1805-11. PubMed ID: 21107086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance].
    Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.